CN108603166A - Direct-Fed Microbials for prevention of shrimp disease - Google Patents
Direct-Fed Microbials for prevention of shrimp disease Download PDFInfo
- Publication number
- CN108603166A CN108603166A CN201780009209.6A CN201780009209A CN108603166A CN 108603166 A CN108603166 A CN 108603166A CN 201780009209 A CN201780009209 A CN 201780009209A CN 108603166 A CN108603166 A CN 108603166A
- Authority
- CN
- China
- Prior art keywords
- bacillus subtilis
- strain
- shrimp
- composition
- rdna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- General Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Purposes the present invention relates to bacillus subtilis strain and its for treating prawn disease such as Deaths syndrome.
Description
Reference to biomaterial preservation library
The application includes the reference to biomaterial preservation, which is incorporated herein by reference.Related complete information ginseng
See example 1.
Reference to sequence table
The application includes the sequence table of a computer-reader form.The computer-reader form is hereby incorporated by reference
This.
It is indexed to sequence table:
SEQ ID NO:1 is the 16S of the bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221
rDNA。
SEQ ID NO:2 be the 16S of the bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220
rDNA。
Technical field
Purposes the present invention relates to bacillus subtilis strain and its for treating prawn disease such as Deaths syndrome.
Background technology
Deaths syndrome (EMS) is also referred to as Acute Hepatic pancreatic necrosis (AHPND), is a kind of relatively new shrimp
Disease currently destroys the production that shrimp generates state such as China, Thailand, Vietnam and Mexico.In one fresh arrangement of storage
In initial 30 days after shrimp ponds, EMS can be broken out naturally, and the death rate can be more than 70%.
Caused by EMS is the one or more bacteriocins propagated by typically direct oral cavity, these bacteriocins are in shrimp gastrointestinal tract
Middle field planting and the one or more toxin for generating the disorganization and dysfunction that lead to shrimp digestive organs (being known as hepatopancrease).
EMS is by the strain of specific vibrios, especially caused by vibrio parahaemolytious.Vibrios EMS bacterial strains are a kind of high poison pathogens, in
State, Thailand and Vietnam cause the up to 80% shrimp death rate.
EMS will need the method different from the strategy of white spot virus is directed at present.Due to the latency development of antibiotic resistance,
Using antibiotic come control microorganism development be undesirable.
Invention content
The present invention relates to the bacillus subtilis strains of the ability with inhibition, control, prevention and/or alleviation EMS
O14VRQ and bacillus subtilis strain MF1048.In being related to replicating five experiments with control treatment, the disease of comparison is sudden and violent
The survival rate of nonvaccinated control shrimp is 0%-10% in 3 days of dew, O14VRQ and MF1048 bacterial strains typically provide 50%-
60% shrimp survival rate.
Therefore, the present invention provides a kind of bacillus subtilis strain of separation, the bacillus subtilis bacterium of the separation
Strain is selected from the group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220.
The invention further relates to one or more in the bacillus subtilis strain comprising separation according to the present invention
With the composition of carrier.
On the other hand, the present invention relates to for treating prawn disease such as EMS (also referred to as Acute Hepatic pancreatic necrosis
(AHPND)) method, the method includes giving one kind in the bacillus subtilis strain of separation according to the present invention or more
The step of kind or composition according to the present invention to shrimp.
On the other hand, the present invention relates to the use of bacillus subtilis strain, the bacillus subtilis strain is selected from
The following group, the group are made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220;
For treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS.
Definition:
In general, term and phrase as used herein have its art-recognized meaning, it can be by reference to this field skill
Received text known to art personnel, periodical literature and context are found.There is provided it is defined below be used for it is clear they draping over one's shoulders
The special-purpose being backless under scape.
As used in this, singulative "one", "an" and "the" be intended to also include plural form, unless up and down
Text clearly dictates otherwise.
Term " about " refer to reference to total amount, level, numerical value, number, frequency, percentage, size, size, quantity, weight or
Length, total amount, level, numerical value, number, frequency, percentage, size, size, quantity, weight or length is changed to more 30%,
25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2% or 1%.
As used herein, term " aquaculture (aquaculture and aquaculturing) " and " aquatic products agricultural
(aquafarm and aquafarming) " can be used alternately, and refer to aquatic or marine animal be typically in artificial environment
In (such as cylinder (for example, aquarium), pond, pond, rice field, lake etc., or animal natural habitat closing or separate
In part (such as pond, pond, rice field, lake, river mouth, ocean, marsh (for example, tidal marsh), lagoon (for example, tidal lagoon) etc.)
In cultivation, cultivation, raising, production, breeding and/or harvest.
As used herein, term " aquatic animal ", " marine animal " or " aquatic and/or marine animal " refer to living in
Biology in water or marine environment.Non-limiting examples include fish, for example, bony fish (includes but not limited to catfish, Rofe
Fish, trout, salmon, perch, Ba Siyu, tuna, wahoo, tuna, arrow fish, marlin, grouper, sturgeon, red porgy, eel and west
Hilsa herring) and cartilaginous fish (include but not limited to shark, devil ray and ray), shell-fish (include but not limited to crab, lobster, crayfish, shrimp,
Krill and prawn) and mollusc (including but not limited to snail, slug, conch, squid, octopus, cuttlefish, clam, oyster, fan
Shellfish and shellfish).In a specific embodiment, the aquatic animal is shrimp or prawn.
As used herein, term " giving (administer, administered or administering) " is intended to
Illustrate that aquatic animal such as shrimp is made to contact with Bacillus strain as described in this or composition.Preferred administration form is mouth
Clothes are given, such as are given via water or via animal feed.
As used herein, such as in for example following phrase:" control (control) " or the micro- life of cause of disease of pathogenic microorganism
" control (controlling) " of object, or such as following phrase:In the species of " control (controlling) " pathogenic microorganism
Term " control (control or controlling) ", refers to any means, and the infection for preventing pathogenic microorganism reduces disease
The quantity of pathogenic microorganism kills pathogenic microorganism, or eliminates pathogenic microorganism, which is as defined in this.
In fact, " control (control or controlling) " as used herein refers in prevention, killing, elimination, reduction or delaying
Solve any success flag in terms of one or more pathogenic bacterias.
Through present disclosure, unless the context otherwise requires, otherwise word " including (comprise, comprises and
Comprising it) " is understood to mean the group for including step or element or multiple steps or element described in one, but is not arranged
Except any other step or element or the group of multiple steps or element.
Term " by ... form " mean include and be limited to phrase " by ... form " intermediate any content.Therefore,
Phrase " by ... form " refer to the element listed it is required or enforceable, and other element can be not present.Term
" substantially by ... form " means to be included in any element listed between the phrase, and is limited to not interfere or contribute to this
The other element of the activity or effect specified for listed elements element in disclosure.Therefore, phrase " substantially by ... form " is
It is required or enforceable to refer to the element listed, but other element is optional and may exist or be not present, this takes
Certainly activity or the effect of listed elements whether are substantially influenced in them.
As used in this, term " spore " and " endospore " are interchangeable and have those skilled in the art
Its general sense that member knows and understands.As used in this, term spore refer in its suspend mode, protected state it is micro-
Biology.
As used in this, term " separation " means that one or more bacterium bacterial strains as the described herein are to be in
In a kind of form or environment that are not present in nature, i.e., one or more bacterium bacterial strains at least partly from its natural phase
It is removed in the one or more or all naturally occurring ingredients closed.
As used in this, term " mixture " means more than one bacterium bacterial strain described herein.
As used herein, term " pathogenic microorganism " mean can to the health of one or more aquatic animals, yield,
Or any microorganism that environment has a negative impact.
As used herein, term " health " refers to biology or the state or situation of its part.
As used herein, term " effective quantity ", " effective concentration " or " effective dose " is defined as being enough to improve aquatic
Amount, concentration or the dosage of the health of animal (such as shrimp) or one or more bacterium bacterial strains of yield.The reality indicated with absolute number
Border effective dose depends on many factors, these factors include:The health status of the aquatic animal discussed;Whether purpose is disease
The prevention or reduction of protozoa, to improve holistic health, intestinal health etc.;Other the existing ingredients, also surface discussed
Or aquatic environment.In one embodiment, for example, one or more bacteriums in disclosed bacillus subtilis strain have
Imitating dosage should be from 1x102To 1x1012In the range of CFU/g compositions, preferably 1x104To 1x109CFU/g compositions, more
Preferably 1x105To 1x108CFU/g compositions, and it is even furthermore preferable that 1x106To 5x108CFU/g compositions.This
Outside, in one embodiment, the mixture involved in bacterium bacterial strain or herein with discussed it is undesirable one or more
Ratio between microorganism can be 1:100,000 and 100,000:(bacterial strain/mixture between 1:Undesirable microorganism), it is excellent
Choosing is 1:10,000 to 10,000:1, more preferably 1:1,000 to 1,000:1, more preferably 1:100 to 100:1, very
To more preferably 1:10 to 10:1." effective quantity ", " effective concentration " or " effective dose " of bacterium bacterial strain can pass through ability
Conventional detection known to the those skilled in the art of domain determines.
As used herein, term " aquatic animal feed " or " aquatic animal feed ingredient " refer to being suitable for or purpose
It is any compound, product or the mixture taken in by aquatic animal (such as shrimp).
As used herein, term " one or more vegetable proteins " refers to including that at least one is derived from or is originated from
Any compound, product or the mixture of the albumen of plant, the albumen include the albumen and protein derivatives of modification.
As used herein, term " granule " and/or " granulation " refer to round solid, spherical shape and/or cylindrical piece or small
Grain, and it is used to form the process of such solid shape, the animal feed that especially feed granule and solid squeeze out.As made herein
, term " squeezing out (extrusion or extruding) " is term well-known in the art, and refers to such place
Description, so that composition is passed through the process in an aperture under stress.
As used herein, term " composition " refers to a kind of composition, and the composition is comprising a kind of carrier and as herein
Described at least one bacterium bacterial strain.Composition described herein can be mixed with one or more animal feeds, and
And " mash feed " can be referred to as.Alternatively, the composition is such as sedimentation feed granule.
Detailed description of the invention
Bacterium bacterial strain
Described herein and disclosure is bacterium bacterial strain, health and happiness, general status or health for improving aquatic animal
And/or yield, improve the weight of such as aquatic animal, improves the whole intestinal health of aquatic animal, and/or the control micro- life of cause of disease
Object (for example, vibrios, vibrio harveyi (Vibrio harveyi), vibrio parahaemolytious, Vibrio campbellii (Vibrio campbellii),
Fermi operator (Vibrio fischeri), luminous bacillus and/or photobacterium phosphoreum (Photobacterium
phosphoreum)).Aquatic animal will be improved by the purpose of this disclosed embodiment being the bacterium bacterial strain that is provided of full text
Health and/or the survival rate of aquatic animal.In a preferred embodiment, the aquatic animal is shrimp.
In a preferred embodiment, the present invention relates to the bacillus subtilis strain of separation, the withered grass of the separation
Bacillus strain is selected from the group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220.
In one embodiment, the bacillus subtilis strain has 16S rDNA sequences, the 16S rDNA sequences
It is selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity.
Preferably, the bacillus subtilis strain have for shrimp pathogens (such as one or more cholerae strains and/
Or luminous bacillus bacterial strain) activity.In a preferred embodiment, the cholerae strain is selected from the group, and the group is by with the following group
At:Fermi operator (Vibrio fischeri), Vibrio vulnificus (Vibrio vulnificus), vibrio fluvialis (Vibrio
Fluvialis), vibrio parahaemolytious, vibrio alginolyticus (Vibrio alginolyticus), vibrio mimicus (Vibrio
Mimicus), comma bacillus (Vibrio cholera), vibrio harveyi (Vibrio harveyi), or any combination thereof.One
In a preferred embodiment, the luminous bacillus bacterial strain is selected from the group, which is made up of:Photobacterium phosphoreum
(Photobacterium phosphoreum), Mermaid luminous bacillus mermaid subspecies (Photobacteria damselae
Subspecies damselae), Mermaid luminous bacillus kill fish subspecies (Photobacterium damselae
Subspecies piscicida) or any combination thereof.
In a preferred embodiment, the bacillus subtilis strain is separation.Preferably implement at another
In example, the bacillus subtilis strain is in the form of spore.
Composition
In one aspect of the invention, a kind of composition is disclosed, the composition is comprising animal feed ingredient and according to this
One or more bacterium bacterial strains of invention.In another embodiment, which be subjected in bacterial strain
The bacterial strain stablized when one extrusion with 1 bar to 35 bar pressures;It is to be subjected to an extrusion in bacterial strain, wherein should
The bacterial strain that extrusion temperature is stablized when being the temperature from 80 DEG C to 120 DEG C;And it is the one or more pathogenic microorganisms of control
Bacterial strain.
In a more specific embodiment, which is selected from the group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220.
In a specific embodiment, the composition includes one kind or more in the bacillus subtilis strain of separation
Kind, the bacillus subtilis strain of the separation is selected from the group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220;
And carrier.The carrier may, for example, be calcium carbonate, other carriers or such as existing referred to such as this paper other parts
Other carriers described in technology.
In a preferred embodiment, the composition includes the bacillus subtilis bacterium with 16S rDNA sequences
Strain, the 16S rDNA sequences are selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;
Or the composition includes with a kind of bacillus subtilis strain and tool by (a) 16S rDNA sequences formed
By second of bacillus subtilis strain of the 16S rDNA sequences being made of (b);
And carrier.
In a preferred embodiment, one or more in the bacillus subtilis strain of the separation in composition are
In the form of spore.
The composition is preferably animal feed or animal feed additive, such as aquatic animal feed or aquatic animal feed
Additive, such as shrimp feed or shrimp feed additive.In one embodiment, the animal feed is feed granule, such as heavy
Feed granule drops.In a specific embodiment, the one kind of feed granule in bacillus subtilis strain according to the present invention
Or a variety of surface coatings.In a preferred embodiment, the composition includes bacillus subtilis strain according to the present invention
From 104To 108CFU/g feeds, such as from 105To 107CFU/g feeds or for example from 5x 106To 9x 106CFU/g feeds.
In one embodiment, composition described herein can have any form, with form (for example, nutrition shape
State or dormant state) it is unrelated, if the carrier can support one or more bacterium bacterial strains, and the composition be suitable for by
Aquatic animal (such as shrimp) is taken in.In certain embodiments, the composition can be following form:Liquid, slurries, solid or powder
Last (wettable powder or dry powder).In a specific embodiment, disclosed composition herein, no matter form, such as liquid
Body, slurries or powder (for example, wettable powder or dry powder), are suitable as a kind of ingredient of animal feed.More at one
In the embodiment of body, composition described herein is suitable as a kind of ingredient of granular fodder.It is more specifically real at another
It applies in example, composition described herein is suitable as the ingredient in a kind of animal feed produced via extrusion.
One or more carriers in composition:
Carrier described here will allow one or more bacterium bacterial strains described here to keep effectively (for example, can change
Kind aquatic animal health and happiness, general status, health or survival rate), and it is vibrant once being formulated.Carrier described here
Non-limiting examples include liquid, slurries or solid (including wettable powder or dry powder).
In one embodiment, which is liquid-carrier.It is useful as the carrier for composition disclosed here
The non-limiting examples of liquid include water, aqueous solution or non-aqueous solution.In one embodiment, which is water.In another reality
It applies in example, which is aqueous solution, such as syrup.In another embodiment, which is non-aqueous solution.If carried using liquid
Body, then liquid (such as water) carrier may further include growth medium, for cultivating one or more bacterium bacterial strains.With
In the non-limiting examples of the suitable growth medium of the bacterium bacterial strain of preservation include arabinose-gluconate (AG), ferment
Female extract mannitol (YEM), G16 culture mediums or well known by persons skilled in the art simultaneous with one or more bacterium bacterial strains
Hold, and/or provide any culture medium of growing nutrient element for it.
In another embodiment, which is slurries.
In another embodiment, which is solid.In a specific embodiment, which is powder.In a reality
It applies in example, which is wettable powder.In another embodiment, which is dry powder.In another embodiment, the solid
It is particle.The non-limiting examples of the solid useful as the carrier for composition disclosed here include calcium carbonate, carbonic acid
Hydrogen sodium, sodium chloride, peat, wheat, wheat shell, the wheat straw of grinding, thick bran, vermiculite, cellulose, starch, soil be (pasteurization
Or non-pasteurization), gypsum, talcum, clay (for example, kaolin, bentonite, montmorillonite) and silica gel.It is specific real at one
It applies in example, which is calcium carbonate.In another embodiment, which is sodium bicarbonate.
One or more bacterium bacterial strains in composition:
Composition as described in this includes one or more bacterium bacterial strains according to the present invention.In one embodiment,
When making one or more bacterium bacterial strains be subjected to feed preparation, which is stable.At one
In specific embodiment, when making one or more bacterial strains be subjected to for granulated extrusion, which is steady
Fixed.
In one embodiment, when making one or more bacterium bacterial strains be subjected to for being reached during granulated extrusion
When the pressure arrived, which is stable.In a specific embodiment, one or more bacterium bacterium
Strain is stable, particularly 10 bars to 40 bars, more particularly 15 bars to 40 bars under the pressure of bar range from 1 bar to 40,
Even more specifically 20 bars to 40 bars, still even more specifically 35 bars to 37 bars, or even still more particularly 36 bars.
In a specific embodiment, which is stable at high temperature.Specifically, when making
Bacterium bacterial strain is subjected in the temperature for being reached during granulated extrusion, these bacterium bacterial strains are stable.One
In a even more specific embodiment, which is stable at a temperature of DEG C range from 80 DEG C to 120
, particularly from 90 DEG C to 120 DEG C range temperature, even more specifically from 95 DEG C to 120 DEG C range temperature.
In another specific embodiment, the extrusion stability of one or more bacterium bacterial strains is by 100 DEG C or 110
Extrusion at DEG C is determining, 50% or more high viability is shown at 100 DEG C, or 25% or higher are shown at 110 DEG C
Survival rate.
In one even more specific embodiment, when one or more bacterium bacterial strains are subjected to an extrusion,
In the extruder have 0.5mm to 5.0mm port mould diameter, which is stable.
In another embodiment, which controls one or more pathogenic microorganisms.
In another embodiment, which is to be subjected to one in bacterial strain to have 1 bar to 40
The bacterial strain stablized when the extrusion of bar pressure;It is to be subjected to an extrusion in bacterial strain, wherein the extrusion temperature is
The bacterial strain stablized when temperature from 80 DEG C to 120 DEG C;And it is the bacterial strain for controlling one or more pathogenic microorganisms.
In a particular embodiment, which will be in 1x102And 1x1012Between CFU/g compositions
Amount exist, particularly in 1x104And 1x109Amount between CFU/g compositions exists, and more particularly with
1x105And 5x108Amount between CFU/g compositions exists.In a more specific embodiment, which will
With in 1x106And 1x108Amount between CFU/g compositions exists.
The fermentation of one or more bacterium bacterial strains can use conventional fermentation process in laboratory or industrial fermentation tank
Middle progress, these conventional fermentation process are for example, aerobic Liquid Culture technology, shaking flask culture and small-scale or extensive hair
Ferment (for example, it is continuous, in batches, batch feeding, solid state fermentation etc.), and this class process is familiar in the field of competence.Although useful
In the production method for producing one or more bacterium bacterial strains, one or more bacterium bacterium from culture medium can be directly used
Strain, or it is subjected to purifying and/or further processing step (for example, drying process).
After fermentation, which can use routine techniques (for example, by filtering, centrifuging)
Recycling.Alternatively, which can be by drying (for example, it is dry to be air-dried, be freeze-dried or spray
It is dry horizontal to low moisture, and it is stored in suitable temperature for example at room temperature).
In one embodiment, disclosed one or more bacterium bacterial strains are stable herein, and are protected when in use
Stop enough a effective amount of activity.Method for producing stable microorganism is well known in the art.In one embodiment
In, one or more bacterium bacterial strains disclosed by this are present in the composition in the form of a kind of resistant spore.
Optional member in composition;
Composition described herein may further include one or more optional ingredients, this it is one or more can
Optional compositions are consumed suitable for aquatic animal (such as shrimp).It is non-limiting can optional member include enzyme.Such components are abilities
Known to the those of ordinary skill in domain.
Enzyme
It includes one or more enzymes as the described herein to further contemplate composition described herein optionally.
In a specific embodiment, which can be the combination of any enzyme or different enzymes that are suitable for administering to animal, meaning
Taste the edible enzyme nutritionally to animal health.Therefore, when referring to " a kind of enzyme ", this usually will be understood to comprise one kind
Or a variety of feed enzymes.In a specific embodiment, it should not be construed as including the enzyme with medical significance Shangdi treatment function.
These feed enzymes should be feed/food-grade, therefore, it is intended that they are harmless to aquatic animal, and
Feed/food-grade means that the pureness specifications recommended for food grade enzyme should be abided by.In a specific embodiment, this anticipates
Taste the enzyme and abides by the pureness specifications recommended for food grade enzyme, and the pureness specifications are by the food additives joint specialist committee
(Joint FAO/WHO Expert Committee on Food Additives) (JECFA) and Food Chemical Codex (Food
Chemical Codex) (FCC) provide.
In a specific embodiment, the enzyme should include less than 30 coliforms/gram, and include be less than 50,000/g
Count plate.
In another embodiment, these compositions described here optionally include one or more enzymes.Enzyme can come
From NC-IUBMB, classify on the basis of enzyme nomenclature (Enzyme Nomenclature) handbook in 1992, it can also be following
Network address is referring to the websites ENZYME:expasy.ch/enzyme/.ENZYME is the information storage cavern relative to enzyme nomenclature.It is main
Based on international bio chemistry and molecular biology federation naming committee (IUB-MB), Academic Press, Inc (Academic
Press, Inc.), 1992 recommendation and each type for describing characterized enzyme provide EC (the enzyme committee) for the enzyme
Number (Bairoch.2000, The ENZYME database [enzyme database], Nucleic Acids Res. [nucleic acids research]
28:304-305).The IUB-MB enzyme nomenclatures are the substrate specificities based on them and once in a while also can be based on their molecules
Mechanism;Such classification does not reflect the structure feature of these enzymes.
Henrissat et al., 2014 in " The carbohydrate-active enzymes database (CAZy)
In2013 [carbohydrate activity enzyme databases in 2013] (CAZy) ", Nucl.Acids Res. [nucleic acids research] (D1):
Certain glycoside hydrolases (such as endoglucanase, zytase, Galactanase, mannosan are described in D490-D495
Enzyme, dextranase, lysozyme and galactosidase) another classification;Referring further to cazy.org.
Therefore, composition of the invention can also include at least one other enzymes selected from the group below, and the group is by with the following group
At:Phytase (EC 3.1.3.8 or 3.1.3.26);Zytase (EC 3.2.1.8);Galactanase (EC 3.2.1.89);
Alpha-galactosidase (EC 3.2.1.22);Protease (EC 3.4), phospholipase A1 (EC 3.1.1.32);Phospholipase A2 (EC
3.1.1.4);Lysophospholipase (EC 3.1.1.5);Phospholipase C (3.1.4.3);Phospholipase D (EC 3.1.4.4);Amylase,
Such as, such as alpha-amylase (EC 3.2.1.1);Lysozyme (EC 3.2.1.17);Arabinofuranosidase (EC
3.2.1.55);Xylobiase (EC 3.2.1.37);Acetyl xylan esterase (EC 3.1.1.72);Feruloyl esterase (EC
3.1.1.73);Cellulase (E.C.3.2.1.4);Cellobiohydrolase (EC 3.2.1.91);β-glucosyl enzym (EC
3.2.1.21);Amylopectase (EC 3.2.1.41) and 1,4 beta-glucanase (EC 3.2.1.4 or EC 3.2.1.6) or its
What mixture.
In a specific embodiment, composition of the invention includes phytase (EC 3.1.3.8 or 3.1.3.26).It can
The example of commercially available phytase includes Bio-FeedTMPhytase (Novi believes (Novozymes)),P、NP andHiPhos (Royal DSM nutrition product company (DSM Nutritional
Products))、NatuphosTM(BASF (BASF)),WithBlue (AB enzymes company (AB
Enzymes))、(Huvepharma)、XP (model grace Nimes/E.I.Du Pont Company (Verenium/
DuPont)) andPHY (E.I.Du Pont Company (DuPont)).Other preferred phytases include being described in such as WO 98/
28408, those of in WO 00/43503 and WO 03/066847.
In a specific embodiment, composition of the invention includes zytase (EC 3.2.1.8).Commercially available wood
The example of dextranase includesWX andG2 (Royal DSM nutrition product company (DSM
Nutritional Products))、XT and Barley (AB Vesta AG & Co. OHG (AB Vista)),
(Verenium Corp. (US) (Verenium)),X (Huvepharma) and(zytase/β-Portugal is poly- by XB
Carbohydrase, E.I.Du Pont Company (DuPont)).
In a specific embodiment, composition of the invention includes protease (EC 3.4).Commercially available protease
Example includesProAct (Royal DSM nutrition product company (DSM Nutritional Products)).
Animal feed
In certain embodiments, composition described herein is (such as a kind of suitable for one or more animal feeds
Or a variety of shrimp feeds) in.The feature of composition described herein allows to be used as in a kind of suitable addition animal feed
Ingredient.In a particular embodiment, by composition described herein and a kind of animal feed ingredient and/or one or more animals
Feed mixes, and is referred to as mash feed.In certain embodiments, then the mash feed is granulated.
The animal feed may include be suitable for aquatic animal (such as shrimp) intake any ingredient, such as including protein,
The source of lipid, sugar, salt, minerals and vitamins.These animal feed ingredients can be selected, and are mixed in any proportion,
It is suitble to the nutritional need of the aquatic animal of satisfaction forage feed, and/or to keep the cost of material of feed in desirable model
In enclosing, and/or to obtain other desirable properties of feed.The non-limiting examples of animal feed ingredient may include following
It is one or more in material:Plant-derived products, for example, seed, grain, leaf, root, stem tuber, flower, pod, crust, oil, dregs of beans,
Soy protein isolate, potato protein powder, wheat, barley, corn and soybean oil and corn gluten meal;Animal derived is produced
Product, such as fish meal, fish oil, milk powder, skimmed milk power, bone extract, meat extract, blood extract, and the like;Addition
Agent, such as minerals, vitamin, aromatic compound and feed enhance enzyme.
In the particular embodiment, animal feed composition may include 0-80% maizes, and/or 0-80% sorghums,
And/or 0-70% wheats, and/or 0-70% barleys, and/or 0-30% oats, and/or 0-40% dregs of beans, and/or 0-10% fishes
Powder, and/or 0-20% wheys.
The animal feed may include vegetable protein.In a particular embodiment, the protein content of these vegetable proteins
At least 10,20,30,40,50,60,70,80 or 90% (w/w).Vegetable protein can be derived from vegetable protein source,
Such as beans and cereal, for example, derived from Papilionaceae (pulse family), Cruciferae, Chenopodiaceae and annual bluegrass section plant material, such as soybean
Muffin, lupin muffin, rapeseed muffin, and combinations thereof.
In a specific embodiment, vegetable protein source is one or more plants from pulse family (Fabaceae)
Material, such as soybean, lupin, pea, beans.In another specific embodiment, vegetable protein source is derived from Chenopodiaceae
One or more plants, for example, beet, sugar beet, spinach or quinoa material.Other examples in vegetable protein source
It is rape and cabbage.In another specific embodiment, soybean is a kind of preferred vegetable protein sources.Vegetable protein sources
Other examples be cereal, such as barley, wheat, rye, oat, maize (corn), rice and sorghum.
In another embodiment, which can optionally include one or more suitable animal feed additions
Agent.The non-limiting examples of suitable animal feed additive include enzyme inhibitor, fat-soluble vitamin, water soluble vitamin,
Trace minerals, a large amount of minerals, and combinations thereof.
In another embodiment, the animal feed can optionally further include one or more feed addictives at
Point.The non-limiting examples of feed addictive ingredient include colorant, aromatic compound, stabilizer, antimicrobial peptide (anti-micro- life
The non-limiting examples of object peptide (AMP) are CAP18, lincomycin (Leucocin) A, Tritrpticin, Protegrin-1, dead
Dying peptide (Thanstin), defense peptide (Defensin), Ovispirin such as Novispirin, (Robert's Lay strangles (Robert
Lehrer), 2000) and its variant or segment (they possess antimicrobial acivity)), anti-fungus peptide (AFP) (non-limiting reality
Example includes huge aspergillus and aspergillus niger peptide, together with its variant and segment (they possess antifungal activity), such as in WO 94/01459
Disclosed in PCT/DK02/00289)), and/or other at least one enzymes, the enzyme be selected from phytase EC 3.1.3.8 or
3.1.3.26;Zytase EC 3.2.1.8;Galactanase EC 3.2.1.89;And/or 1,4 beta-glucanase EC 3.2.1.4.
In still another embodiment, which can also optionally include further one or more fat-soluble dimensions
Raw element or water soluble vitamin, trace minerals and a large amount of minerals.In general, liposoluble vitamin-and water-soluble-property vitamin,
And trace minerals form a kind of so-called part for being intended to be added to the premix in feed, and a large amount of minerals are usual
It is separately added in feed.
The non-limiting examples of fat-soluble vitamin include vitamin A, vitamine D3, vitamin E and vitamin K,
Such as Vitamin K3.
The non-limiting examples of water-soluble vitamin include vitamin B12, biotin and choline, vitamin B1, vitamin
B2, vitamin B6, niacin, folic acid and pantothenate, such as Ca-D- pantothenates.
The non-limiting examples of trace minerals include boron, cobalt, chloride, chromium, copper, fluoride, iodine, iron, manganese, molybdenum, selenium,
Zinc etc..
The non-limiting examples of a large amount of minerals include calcium, magnesium, potassium, sodium etc..
Processing method
In one embodiment, a kind of health and happiness, method of general status or health for improving aquatic animal is disclosed,
This method includes giving a effective amount of one or more bacterium bacterial strains to aquatic animal (such as shrimp).In a specific embodiment
In, this method includes contacting the enteron aisle of aquatic animal with one or more bacterium bacterial strains.Even more specifically implement at one
In example, these bacterium bacterial strains can control and/or inhibit the species of vibrios, luminous bacillus and/or a combination thereof.
The present invention relates to a kind of method for treating prawn disease such as EMS, this method includes giving the withered grass gemma of separation
The step of one or more in bacillus strain are to shrimp, the bacillus subtilis strain of the separation is selected from the group, the group by with
Lower composition:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220.
The invention further relates to a kind of method for treating prawn disease such as EMS, this method includes giving with 16S
One or more steps in the bacillus subtilis strain of the separation of rDNA sequences, the 16S rDNA sequences are selected from down
Group, the group are made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity.
This method preferably includes to give daily at least 2 days, such as 3,4,5,6,7,8,9,10 or (coherent or non-more than 10 days
Coherent number of days).
This method preferably includes the bacillus subtilis according to the present invention of every aquatic animal (such as shrimp of every 5g)
The daily dosage of the 1.5x10E6CFU of bacterial strain.In another embodiment, this method includes every aquatic animal (such as every
The shrimp of 5g) the 0.9x10E6 to 6.0x10E6CFU according to bacillus subtilis strain of the present invention daily dosage.Again another
In a embodiment, this method includes every aquatic animal (such as shrimp of every 5g) according to bacillus subtilis strain of the present invention
Slave 0.1x10E6 to 1.0x10E7CFU daily dosage, such as dosage selected from the group below, the group be made up of:Every water
Lively object (such as shrimp of every 5g) from 0.1x10E6 to 0.5x10E6, from 0.5x10E6 to 1.0x10E6, from 1.0x10E6 to
2.0x10E6, from 2.0x10E6 to 3.0x10E6, from 3.0x10E6 to 4.0x10E6, from 4.0x10E6 to 5.0x10E6, from
5.0x10E6 to 6.0x10E6, from 6.0x10E6 to 7.0x10E6, from 7.0x10E6 to 8.0x10E6, from 8.0x10E6 to
9.0x10E6, from 9.0x10E6 to 1.0x10E7CFU or any combination of bacillus subtilis according to the present invention at these intervals
Bacteria strain.
In another preferred embodiment, with control (the bacillus subtilis bacterium according to the present invention detached is not given
Strain) it compares, which leads to the survival rate increase at least 20% of shrimp, such as increases at least 30%, for example increases by least 40%, example
As increased at least 50% or for example increasing at least 60% survival rate.
The invention further relates to the bacillus subtilis strain of separation, the bacillus subtilis strain of the separation is selected from down
Group, the group are made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220,
For being used as drug.
The invention further relates to the bacillus subtilis strain of the separation with 16S rDNA sequences, the rDNA sequences are selected from
The following group, the group are made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity.
The invention further relates to the bacillus subtilis strain of separation, the bacillus subtilis strain of the separation is selected from
The following group, the group are made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220,
For treating prawn disease such as EMS.
The invention further relates to the bacillus subtilis strain of the separation with 16S rDNA sequences, the rDNA sequences are selected from
The following group, the group are made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;
For treating prawn disease such as EMS.
In another embodiment, the present invention relates to the purposes of bacillus subtilis strain, the bacillus subtilis bacterium
Strain is selected from the group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220;
For treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS.
In still another embodiment of this method, which exists with stable spore form.
In still another embodiment of this method, the spore of the stabilization will be sprouted in the enteron aisle of aquatic animal.
In a specific embodiment, this method includes giving one or more to be retouched at this to aquatic animal (such as shrimp)
The bacterial population of the bacterium bacterial strain stated, wherein one or more bacterium bacterial strains is in 1x102And 1x1012Between CFU/g compositions,
Particularly in 1x104And 1x109Between CFU/g compositions, and more particularly in 1x105And 5x108CFU/g compositions
Between.In a more specific embodiment, the bacterial population of one or more bacterium bacterial strains described herein is in 1x106
And 1x108Between CFU/g compositions.
In one even more specific embodiment, this method include by the enteron aisle of aquatic animal (such as shrimp) with it is a kind of or more
The step of kind bacterium bacterial strain contact, wherein one or more bacterium bacterial strains are selected from the group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220.
In still another embodiment of this method, which exists with stable spore form.
In still another embodiment of this method, the spore of the stabilization will be sprouted in the enteron aisle of aquatic animal.
In a specific embodiment, this method include by the enteron aisle of aquatic animal (such as shrimp) with it is one or more herein
Described bacterium bacterial strain contact, wherein one or more bacterium bacterial strains are improved aquatic dynamic by increasing aquatic animal weight
Object health.In still another embodiment, one or more bacterium bacterial strains by enhance aquatic animal immune system and/or
Immune response is healthy to improve aquatic animal.In another embodiment, one or more bacterium bacterial strains are by improving water
The holistic health of the enteron aisle of lively object improves aquatic animal health.The non-limiting examples packet reduction for improving enteron aisle includes enteritis
Disease, the length for increasing intestinal villus and/or surface area, the nutrient absorption for increasing intestinal crypts depth, improving enteron aisle, keep and/or
Improve healthy intestinal microflora group, or combinations thereof.In still still another embodiment, which passes through control
Pathogenic microorganism is healthy to improve aquatic animal.In a specific embodiment, which passes through control
Pathogenic microorganism in aquatic animal enteron aisle improves the health of aquatic animal.
In yet another embodiment, which, which controls, belongs to vibrio and/or luminous bacillus bacterium
The pathogenic microorganism of strain.In a more specific embodiment, the one or more bacterium bacterial strains for controlling pathogenic microorganism are selected from down
Group, the group are made up of:Fermi operator (Vibrio fischeri), Vibrio vulnificus (Vibrio vulnificus), river
Vibrios (Vibrio fluvialis), vibrio parahaemolytious, vibrio alginolyticus (Vibrio alginolyticus), vibrio mimicus
(Vibrio mimicus), comma bacillus (Vibrio cholera), vibrio harveyi (Vibrio harveyi), bright burn bar
Bacterium (Photobacterium phosphoreum), Mermaid luminous bacillus mermaid subspecies (Photobacteria
Damselae subspecies damselae), Mermaid luminous bacillus kill fish subspecies (Photobacterium damselae
Subspecies piscicida) or any combination thereof.
In a specific embodiment, which is a kind of fish (for example, catfish, Tilapia mossambica, trout, salmon, perch
Fish, Ba Siyu, tuna, wahoo, tuna, arrow fish, marlin, grouper, sturgeon, red porgy, eel and western hilsa herring, shark, devil ray and
Ray), a kind of crustacean (for example, crab, lobster, crayfish, shrimp, krill and prawn), a kind of mollusk (such as snail, Kuo
Yu, conch, squid, octopus, cuttlefish, clam, oyster, scallop and shellfish), and combinations thereof.In a kind of even more specific embodiment
In, which is a kind of fish, a seed shrimp, a kind of lobster, a kind of eel, a kind of crayfish, a kind of prawn, a seed oyster, one kind
Shellfish, a kind of cockle, or combinations thereof.In one even more specific embodiment, which is a kind of catfish, Yi Zhongluo
Non- fish, a seed shrimp or combinations thereof.
The invention further relates to purposes of the bacterium bacterial strain according to the present invention in aquaculture.
Manufacturing process
In still another embodiment, method described herein includes giving combination described herein to aquatic animal
Object and/or the enteron aisle of aquatic animal (such as shrimp) is contacted with composition described herein.In a specific embodiment, should
Composition is the ingredient of animal feed as described herein (that is, mash feed).
In a preferred embodiment, bacterial spore according to the present invention is mixed into calcium carbonate carrier (such as #
1491Vicron 45-3FG) in formed from be initially spray-dried spore concentrate (be usually 5-9x10e9CFU/g extremely
5-9x10e11, such as CFU/g 5-9x10e10CFU/g) product (target is preferably 1x10e8CFU/g to 1x10e10CFU/
G, for example, 1x10e9CFU/g).The preparation is stablized at least 2 years typically at RT (23 DEG C).In use, product typically with
1:5g/g to 1:20g/g suspends, such as 1:10g/g is in such as in water or vegetable oil, to provide such as 1x10e8CFU/ml's
Suspension.It is preferred that the material is equably sprayed on pre-formed feed granule, such as with 5% to 20%v/g rate, example
Such as the rate of 10%v/g, and it is dried overnight at such as 21 DEG C -30 DEG C.The gained of spore according to the present invention on granule
To 6-8x 10e8CFU/g feeds, for example, about 6-8x 10e6CFU/g are raised recyclable horizontal preferably 6-8x 10e5CFU/g feeds
Material.In a specific embodiment, the bacterial concentration on feed granule is from 1x 10e5CFU/g feeds to 8x 10e8CFU/g
Feed, for example from 1x 10e5CFU/g feeds to 8x 10e5CFU/g feeds, for example from 8x 10e5CFU/g feeds to 1x
10e6CFU/g feeds, for example from 1x 10e6CFU/g feeds to 1x 10e7CFU/g feeds, for example from 1x 10e7CFU/g feeds
To 1x 10e8CFU/g feeds or any combinations at these intervals.
In one even more specific embodiment, which is granular.Granulation is known in this field.
In a specific embodiment, these granules are produced by granulation.In another embodiment, these granules are by squeezing
Go out process to be produced.
In one embodiment, which can be by that will include one or more bacterium bacterium
The composition of strain is mixed with desirable feed ingredient to prepare.In a specific embodiment, the mash feed can be through
It is adjusting or unregulated.
In one embodiment, which is after the adjustment before granulation.In a specific embodiment,
The mash feed is directed to an adjuster, for example, in the cascade of mixers with steam injection.The feed is in the regulators
It is heated to by injection steam and exports measured actual temp in adjuster, such as 60 DEG C -120 DEG C, for example, 60 DEG C,
70 DEG C, 80 DEG C, 90 DEG C, 100 DEG C, 105 DEG C, 110 DEG C, 115 DEG C or 120 DEG C.Residence time can from several seconds to a few minutes, and
And even a few houres change.Such as 5 seconds, 10 seconds, 15 seconds, 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes,
30 minutes, 1 hour, 2 hours, 3 hours, 4, hour, 5 hours, 6 hours, 7 hours, 8, hour, 9 are hour, 10 hours, 11 small
When, 12 hours and up to 24 hours and more long.In a specific embodiment, the process temperature during steam treatment is
At least 60 DEG C.In a more specific embodiment, the process temperature during steam treatment is at least 70 DEG C.Even at one
In more specific embodiment, the process temperature during steam treatment is at least 80 DEG C.In an embodiment most specifically,
Process temperature during steam treatment is at least 90 DEG C.
In another embodiment, which is an extrusion.Typical case for producing feed granule squeezed out
Journey is known to the person skilled in the art.Extrusion or granulated product, wherein the forage mixture (mash feed) is pressed into
Granule passes under pressure through a small opening extrusion, and is cut into particle, these particles are then dried.This particle
Usually there is sizable size, limited because being provided with the material (tablet typically with drilling) for squeezing out and being open by squeezing
Go out the admissible pressure drop that is open.In addition, when using small opening, very high extrusion pressure increases the heat of mash feed
Occur.(Michael S.Showell (editor);Powdered detergents;Surfactant Science Series
[detergent powder;Surfactant science series];1998;Volume 71;The 140-142 pages;Marcel De Keer publishing houses
(Marcel Dekker))。
In a specific embodiment, which is introduced into extruder to form the variable-length from extrudate
Granule.The extrusion equipment can be any screw-type extruder known in the art.In a specific embodiment, the extruder
It is a kind of Twin screw extruder, such as the continuous 37 " extruder of Werner&Pfleiderer types.Extrusion parameter is (for example, capacity, spiral shell
Bar rotating speed, port mould diameter, drying temperature, drying time etc.) depend on particle extrusion and/or used extrusion equipment.
In one embodiment, the screw speed of the extruder is 1-1,000RPM.In a more specific embodiment,
The screw speed of the extruder is 100RPM.In one even more specific embodiment, the screw speed of the extruder is
150RPM.In another even more specific embodiment, the screw speed of the extruder is 200RPM.Even more at still one
In specific embodiment, the screw speed of the extruder is 250RPM.Still another even more in specific embodiment, this is squeezed
The screw speed for going out machine is 300RPM.
In one embodiment, which is 0.5mm -5.0mm.In a more specific embodiment, the mouth mold
Diameter is 0.5mm.In one even more specific embodiment, which is 1.0mm.It is even more specific at another
In embodiment, which is 1.5mm.In an embodiment most specifically, which is 2.0mm.
Place the granule then dry one specific time, for example, at least 15 minutes, preferably 20 minutes, 60 DEG C-
At a temperature of 100 DEG C, preferably 90 DEG C -100 DEG C, more preferably 90 DEG C, it is even furthermore preferable that 95 DEG C, it is even still more excellent
Choosing is 100 DEG C.
Preferred embodiment
The preferred embodiment of the present invention is given in one group of project below.
1. a kind of bacillus subtilis strain of separation, the bacillus subtilis strain of the separation are selected from the group, the group
It is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220.
2. a kind of bacillus subtilis strain of separation, with 16S rDNA sequences, the 16S rDNA sequences are selected from
The following group, the group are made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity.
3. the bacillus subtilis strain according to project 1 or 2, wherein the bacterial strain has the work of anti prawn disease substance
The growth of property and/or inhibition/limitation shrimp pathogens.
4. according to the bacillus subtilis strain described in project 3, wherein the shrimp pathogens are cholerae strains.
5. according to the bacillus subtilis strain described in project 4, wherein the cholerae strain is selected from the group, the group is by following
Composition:Fermi operator (Vibrio fischeri), Vibrio vulnificus (Vibrio vulnificus), vibrio fluvialis (Vibrio
Fluvialis), vibrio parahaemolytious, vibrio alginolyticus (Vibrio alginolyticus), vibrio mimicus (Vibrio
Mimicus), comma bacillus (Vibrio cholera), vibrio harveyi (Vibrio harveyi).
6. according to the bacillus subtilis strain described in project 3, wherein the shrimp pathogens are luminous bacillus bacterial strains.
7. according to the bacillus subtilis strain described in project 6, wherein the luminous bacillus bacterial strain is selected from the group, the group by
Consisting of:Photobacterium phosphoreum (Photobacterium phosphoreum), Mermaid luminous bacillus mermaid subspecies
(Photobacteria damselae subspecies damselae), Mermaid luminous bacillus kill fish subspecies
(Photobacterium damselae subspecies piscicida) or any combination thereof.
8. the bacillus subtilis strain according to any one of project 1 to 7, wherein the bacillus subtilis strain
Causing shrimp shrimp survival rate to be at least 15% after 104 hours, (feeding shrimp contains the vibrio parahaemolytious pathogen as described in example 2
After the standard diet of bacillus subtilis strain) such as shrimp survival rate is at least 20%, at least 25% or extremely after 104 hours
Few 30%.
9. the bacillus subtilis strain according to any one of project 1 to 8, wherein the bacterial strain is subjected to for grain
When temperature when the pressure reached during the extrusion of change and during the extrusion is 105 DEG C or lower, such as
For range from 80 DEG C to 105 DEG C, which is stable.
10. the bacillus subtilis strain according to any one of project 1 to 9, wherein the bacterial strain is in pressure limit
For from 1 bar to 40 bar, for example, from 10 bars to 40 bar, from 15 bars to 40 bar, from 20 bars to 40 bar, from 35 bars to 37 bar or 36
Bar, and temperature is 105 DEG C or lower, such as range, from 80 DEG C to 105 DEG C, which is stable.
11. the bacillus subtilis strain according to any one of project 1 to 10, wherein the bacterial strain be subjected to for
When the temperature reached during granulated extrusion, for example, temperature range from 80 DEG C to 105 DEG C, from 90 DEG C to 105 DEG C or
At from 95 DEG C to 105 DEG C, which is stable.
12. the bacillus subtilis strain according to any one of project 1 to 11, wherein the bacterial strain is subjected to have
1 bar to 40 bar pressures and an extrusion of 80 DEG C to 105 DEG C of temperature when, which is stable, and the bacterial strain control
Make one or more pathogenic microorganisms.
13. a kind of composition, the composition includes the bacillus subtilis of the separation according to any one of project 1 to 12
One or more and carrier in bacteria strain.
14. a kind of composition, the composition includes the withered grass gemma of one or more separation with 16S rDNA sequences
Bacillus strain, the 16S rDNA sequences are selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity,
And carrier.
15. the composition according to any one of project 13 to 14, wherein the bacillus subtilis strain of the separation
In it is one or more be in the form of spore.
16. the composition according to any one of project 13 to 15, wherein the carrier is selected from the group, the group is by following
Composition:Liquid, slurries and/or solid.
17. the composition according to any one of project 13 to 16, wherein the composition is animal feed, such as water
Raw animal feed, such as shrimp feed or animal feed additive, such as aquatic animal feed additive, such as shrimp feed addition
Agent.
18. according to the composition described in project 17, wherein the animal feed is feed granule, such as sedimentation feed granule
Or puffing granule, such as buoyancy granule.
19. according to the composition described in project 18, wherein the feed granule is with according to described in any one of item 1 to 12
Bacillus subtilis strain surface coatings.
20. the composition according to any one of project 13 to 19, wherein the composition includes bacillus subtilis
Bacterial strain from 104To 108CFU/g feeds, such as from 105To 107CFU/g feeds or for example from 5x 106To 9x 106CFU/g is raised
Material.
21. method of the one kind for treating prawn disease such as Deaths syndrome (EMS), the method includes giving basis
One or more in the bacillus subtilis strain of separation described in any one of project 1 to 12 or according in project 13 to 20
The step of any one of them composition to shrimp.
22. a kind of method for treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS, the method includes
Give one or more in the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project
The step of composition to shrimp described in any one of 13 to 20.
23. the method according to project 21 or 22, wherein described give including giving daily at least 2 days, such as 3,4,
5,6,7,8,9,10 or more than 10 days (coherent or non-coherent number of days).
24. the method according to any one of project 21 to 23, wherein (not given according in project 1 to 12 with compareing
The bacillus subtilis strain or the composition according to any one of project 13 to 20 of any one of them separation) it compares,
The treatment causes the survival rate of shrimp at least to increase by 10%, for example, at least 20%, for example, at least 30%, for example, at least 40%, example
Such as at least 50%, for example, at least 60% or for example, at least 70% higher survival rate.
25. the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project 13 to 20
Any one of described in composition be used for be used as drug.
26. the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project 13 to 20
Any one of described in composition for treating prawn disease such as EMS.
27. the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project 13 to 20
Any one of described in composition for treating shrimp Poisoning vibrio parahaemolytious relevant disease such as EMS.
28. the purposes of one or more bacillus subtilis strains, one or more bacillus subtilis strain choosings
From the following group, which is made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis
The bacterial strain or its mutant of all diagnostic characteristics of bacteria strain NRRL B-67220;
For treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS.
29. the purposes of the bacillus subtilis strain of one or more separation with 16S rDNA sequences, the 16S
RDNA sequences are selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity,
For treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS.
30. according to the purposes described in project 28, wherein the bacillus subtilis strain has 16S rDNA sequences, it is described
16S rDNA sequences are selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least
98.15%, at least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least
98.45%, at least 98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least
98.75%, at least 98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least
99.05%, at least 99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least
99.35%, at least 99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least
99.65%, at least 99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least
The 16s rDNA of 99.95% or 100% sequence identity;Or
One of which bacillus subtilis strain has the 16S rDNA sequences being made of (a), and second of withered grass bud
Spore bacillus strain has the 16S rDNA sequences being made of (b).
31. the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project 13 to 20
Any one of described in purposes of the composition in manufacturing drug.
32. the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project 13 to 20
Any one of described in purposes of the composition in drug of the manufacture for treating prawn disease such as EMS.
33. the bacillus subtilis strain of the separation according to any one of project 1 to 12 or according to project 13 to 20
Any one of described in composition in drug of the manufacture for treating shrimp Poisoning vibrio parahaemolytious relevant disease such as EMS
Purposes.
Example
Example 1
Biomaterial preservation
According to the clause of budapest treaty, in Agricultural Research Service Patent Culture Collection
(Agricultural Research Service Patent Culture Collection (NRRL)), North research center
(Northern Regional Research Center), No. 1815, university street, skin Austria Rhea (Peoria), Illinois
State, 61604, the U.S., the following biomaterial of preservation, and provide following accession number:
Preserved material | Accession number | Preservation date |
Bacillus subtilis O14VRQ | NRRL B-67221 | On January 8th, 2016 |
Bacillus subtilis MF1048 | NRRL B-67220 | On January 8th, 2016 |
Bacillus subtilis strain O14VRQ is on May 5th, 2006 by coming from Novozymes North America, Inc. (Novozymes
North America, Inc.) Michael Frodyma separated from Virginia, the pedotheque in the U.S..
Bacillus subtilis strain MF1048 is on October 4th, 2005 by coming from Novozymes North America, Inc. (Novozymes
North America, Inc.) Michael Frodyma separated from Virginia, the pedotheque in the U.S..
Bacterial strain preservation under the conditions of following:Ensure in present patent application pending period, according to the foreign patent law
The people of mandate can obtain the culture.The preserved material represents the substantially pure culture of institute's preservation strain.It needs
By some country foreign patent method requirement provide preserved material, these country submit the subject applications copy or its subsequently
Text.Present subject matter is used to be weighed by action by government patent granted it should be understood, however, that the availability of preserved material is not constituted
The license of practice.
Example 2
Table 1 shows the relative survival rate of eight kinds of shrimp feed diets respectively containing one of 8 kinds of bacillus candidate strains.It raises
Feed bacillus subtilis strain NRRL B-67221 (O14VRQ) or bacillus subtilis strain NRRL B-67220 (MF1048)
Shrimp have bigger more notable than other six kinds of Bacillus strains survival rate.Three cylinders are each handled, are had in every 10 gallons of cylinders
Ten shrimps (each 30 shrimps of processing) are for the shrimp survival rate during comparing 104 hours.All shrimps all feeding standard quantity
Business shrimp feed granule, these business shrimp feed granules are directly small in feed by surface spray 24 hours before feeding
On grain, handled with specified bacillus organism.Specifically, the water miospore suspension of each processing bacterium is prepared, preferably
A concentration of 0.6x 10E8CFU/ml to 1.2x 10E8CFU/ml.Suspension is equal with the preferred rate of 1.0ml spore suspensions
It is sprayed to evenly on dry feed granule (sedimentation), until the feed granule of 10.0g, and it is allowed to be dried overnight at 4 DEG C -23 DEG C.
The recyclable bacterial concentration of gained on granule is 0.6-1.2x 10E7CFU/g- feeds.By the granule of processing (in subsequent disease
After substance inoculation;See below) it is added in each specified cylinder with the rate of the shrimp weight of daily 3% (w/w).For this research
In all shrimps, average weight be 5g/ shrimps, target inoculum concentration be 0.15g- feeds/shrimp/day or 1.5x 10E6CFU/ shrimps it is daily.
When testing beginning (0 hour time), all shrimps (100%) are healthy and size is similar.
Vibrio parahaemolytious pathogen is introduced into each test group via feeding inoculation.Originate vibrio parahaemolytious culture
(OD6000.5) can in various commercial mediums, such as pancreas peptone soybean broth (TSB), Luria meat soups (LB) or other
It is grown in suitable culture medium.For these researchs, vibrio parahaemolytious is inoculated into and is supplemented with other 2%NaCl (TSB2+)
Pancreas peptone soybean broth in, and cultivate 18 hours (inoculation) in the incubator for being set as stirring with 250rpm at 30 DEG C.
The vibrio parahaemolytious bacterial strain concentration grown in entire processing is measured using Standard Plate Count method, when ensuring all inoculums
Between the identity property put.
(18 hours cultures of vibrio parahaemolytious pathogen) will be inoculated with 1:1 ratio (milliliter is seeded to a gram feed) is applied
With in the feed of the subtilis spore processing (as described above) of test before being added to.Before being introduced into shrimp cylinder, allow to be inoculated with
It is absorbed into feed three minutes.Every eight hours and 24 hours assessment shrimp survival rates dduring test.Before each feeding, by solid
Waste is extracted out from water to reduce the nitrogenouz wastes that may cause water quality inferiority, and if it find that dead shrimp is then removed.Every 24 is small
When into shrimp cylinder introduce inoculation vibrio parahaemolytious feed, observed until in control group (not adding bacillus)
The 50% shrimp death rate.After that, only standard (non-disease) feed is added in all cylinders.
Shrimp survival rate (%)
Table 1:Feeding adds the standard diet of various Bacillus strains containing vibrio parahemolyticus pathogen (high level)
Shrimp survival rate afterwards.
Table 2 shows the relative survival rate of four kinds of shrimp feed diets, each feed diet contains from four kinds of independent spores
Criticize preparation (O14VRQ-NA;O14VRQ-HA;O14VRQ-NASD;And O14VRQ-ASD) bacillus subtilis strain NRRL
B-67221(O14VRQ).In our current research, compared with untreated disease is inoculated with control (NTC+), all four bacillus
Spore preparation confirms 40% to 50% disease survival rate.Feeding is not inoculated with vibriosis and unused Bacillus strain (NTC-)
The shrimp survival rate of processing is 100%.
Shrimp survival rate (%)
Table 2:Feeding adds the bud from four kinds of different spore batch preparations containing vibrio parahaemolytious pathogen (medium level)
Shrimp survival rate after the standard diet of spore bacillus strain O14VRQ (NRRL B-67221).
Sequence table
<110>Novozymes Company (Novozymes A/S)
<120>Direct-Fed Microbials for prevention of shrimp disease
<130> 14102-WO-PCT
<150> US 62/298,578
<151> 2016-02-23
<160> 2
<170>PatentIn version 3s .5
<210> 1
<211> 1259
<212> DNA
<213>Bacillus subtilis
<400> 1
acgatgcgta gccgacctga gagggtgatc ggccacactg ggactgagac acggcccaga 60
ctcctacggg aggcagcagt agggaatctt ccgcaatgga cgaaagtctg acggagcaac 120
gccgcgtgag tgatgaaggt tttcggatcg taaagctctg ttgttaggga agaacaagta 180
ccgttcgaat agggcggtac cttgacggta cctaaccaga aagccacggc taactacgtg 240
ccagcagccg cggtaatacg taggtggcaa gcgttgtccg gaattattgg gcgtaaaggg 300
ctcgcaggcg gtttcttaag tctgatgtga aagcccccgg ctcaaccggg gagggtcatt 360
ggaaactggg gaacttgagt gcagaagagg agagtggaat tccacgtgta gcggtgaaat 420
gcgtagagat gtggaggaac accagtggcg aaggcgactc tctggtctgt aactgacgct 480
gaggagcgaa agcgtgggga gcgaacagga ttagataccc tggtagtcca cgccgtaaac 540
gatgagtgct aagtgttagg gggtttccgc cccttagtgc tgcagctaac gcattaagca 600
ctccgcctgg ggagtacggt cgcaagactg aaactcaaag gaattgacgg gggcccgcac 660
aagcggtgga gcatgtggtt taattcgaag caacgcgaag aaccttacca ggtcttgaca 720
tcctctgaca atcctagaga taggacgtcc ccttcggggg cagagtgaca ggtggtgcat 780
ggttgtcgtc agctcgtgtc gtgagatgtt gggttaagtc ccgcaacgag cgcaaccctt 840
gatcttagtt gccagcattc agttgggcac tctaaggtga ctgccggtga caaaggaatt 900
gacgggggcc cgcacaagcg gtggagcatg tggtttaatt cgaagcaacg cgatgctaca 960
atggacagaa caaagggcag cgaaaccgcg aggttaagcc aatcccacaa atctgttctc 1020
agttcggatc gcagtctgca actcgactgc gtgaagctgg aatcgctagt aatcgcggat 1080
cagcatgccg cggtgaatac gttcccgggc cttgtacaca ccgcccgtca caccacgaga 1140
gtttgtaaca cccgaagtcg gtgaggtaac cttttaggag ccagccgccg aaggtgggac 1200
agatgattgg ggtgaagtcg taacaaggta gccgtatcgg aaggtgcggc tggatcacc 1259
<210> 2
<211> 1273
<212> DNA
<213>Bacillus subtilis
<400> 2
acgatgcgta gccgacctga gagggtgatc ggccacactg ggactgagac acggcccaga 60
ctcctacggg aggcagcagt agggaatctt ccgcaatgga cgaaagtctg acggagcaac 120
gccgcgtgag tgatgaaggt tttcggatcg taaagctctg ttgttaggga agaacaagta 180
ccgttcgaat agggcggtac cttgacggta cctaaccaga aagccacggc taactacgtg 240
ccagcagccg cggtaatacg taggtggcaa gcgttgtccg gaattattgg gcgtaaaggg 300
ctcgcaggcg gtttcttaag tctgatgtga aagcccccgg ctcaaccggg gagggtcatt 360
ggaaactggg gaacttgagt gcagaagagg agagtggaat tccacgtgta gcggtgaaat 420
gcgtagagat gtggaggaac accagtggcg aaggcgactc tctggtctgt aactgacgct 480
gaggagcgaa agcgtgggga gcgaacagga ttagataccc tggtagtcca cgccgtaaac 540
gatgagtgct aagtgttagg gggtttccgc cccttagtgc tgcagctaac gcattaagca 600
ctccgcctgg ggagtacggt cgcaagactg aaactcaaag gaattgacgg gggcccgcac 660
aagcggtgga gcatgtggtt taattcgaag caacgcgaag aaccttacca ggtcttgaca 720
tcctctgaca atcctagaga taggacgtcc ccttcggggg cagagtgaca ggtggtgcat 780
ggttgtcgtc agctcgtgtc gtgagatgtt gggttaagtc ccgcaacgag cgcaaccctt 840
gatcttagtt gccagcattc agttgggcac tctaaggtga ctgccggtga caaaccggag 900
gaaggtgggg atgacgtcaa atcatcatgc cccttatgac ctgggctaca cacgtgctac 960
aatggacaga acaaagggca gcgaaaccgc gaggttaagc caatcccaca aatctgttct 1020
cagttcggat cgcagtctgc aactcgactg cgtgaagctg gaatcgctag taatcgcgga 1080
tcagcatgcc gcggtgaata cgttcccggg ccttgtacac accgcccgtc acaccacgag 1140
agtttgtaac acccgaagtc ggtgaggtaa ccttttagga gccagccgcc gaaggtggga 1200
cagatgattg gggtgaagtc gtaacaaggt agccgtatcg gaaggtgcgg ctggatcacc 1260
tcctttctaa gga 1273
Claims (15)
1. a kind of bacillus subtilis strain of separation, the bacillus subtilis strain of the separation are selected from the group, the group by with
Lower composition:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis bacterium
The bacterial strain or its mutant of all diagnostic characteristics of strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis bacterium
The bacterial strain or its mutant of all diagnostic characteristics of strain NRRL B-67220.
2. a kind of bacillus subtilis strain of separation, with 16S rDNA sequences, the 16S rDNA sequences are selected from the group,
The group is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least 98.15%,
At least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least 98.45%, at least
98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least 98.75%, at least
98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least 99.05%, at least
99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least 99.35%, at least
99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least 99.65%, at least
99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least 99.95% or 100% sequence
The 16s rDNA of row consistency;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least 98.15%,
At least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least 98.45%, at least
98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least 98.75%, at least
98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least 99.05%, at least
99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least 99.35%, at least
99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least 99.65%, at least
99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least 99.95% or 100% sequence
The 16s rDNA of row consistency.
3. bacillus subtilis strain as claimed in claim 1 or 2, wherein the bacterial strain has the activity of anti prawn disease substance,
And/or the growth of inhibition/limitation shrimp pathogens.
4. bacillus subtilis strain as claimed any one in claims 1 to 3, wherein the bacillus subtilis strain is led
It causes shrimp shrimp survival rate be at least 15% after 104 hours (to feed shrimp and contain vibrio parahaemolytious pathogen described in example 2 and withered
After the standard diet of careless Bacillus strain) such as shrimp survival rate is at least 20%, at least 25% or at least after 104 hours
30%.
5. a kind of composition, the composition includes the bacillus subtilis bacterium detached according to any one of claims 1 to 4
One or more and carrier in strain.
6. a kind of composition, the composition includes the bacillus subtilis bacterium of one or more separation with 16S rDNA sequences
Strain, the 16S rDNA sequences are selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least 98.15%,
At least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least 98.45%, at least
98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least 98.75%, at least
98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least 99.05%, at least
99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least 99.35%, at least
99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least 99.65%, at least
99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least 99.95% or 100% sequence
The 16s rDNA of row consistency;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least 98.15%,
At least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least 98.45%, at least
98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least 98.75%, at least
98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least 99.05%, at least
99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least 99.35%, at least
99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least 99.65%, at least
99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least 99.95% or 100% sequence
The 16s rDNA of row consistency,
And carrier.
7. the composition as described in any one of claim 5 or 6, wherein one in the bacillus subtilis strain of the separation
Kind or it is a variety of be in the form of spore.
8. the composition as described in any one of claim 5 to 7, wherein the carrier is selected from the group, which is made up of:
Liquid, slurries and/or solid.
9. the composition as described in any one of claim 5 to 8, wherein the composition is animal feed, for example (,) it is aquatic dynamic
Object feed, such as shrimp feed or animal feed additive, such as aquatic animal feed additive, such as shrimp feed additive.
10. method of the one kind for treating prawn disease such as Deaths syndrome (EMS), the method includes giving right such as to want
It asks and appoints in the one or more or such as claim 5 to 9 in the bacillus subtilis strain of the separation described in any one of 1 to 4
The step of composition to shrimp described in one.
11. method as claimed in claim 10, wherein (not given according to any one of claims 1 to 4 with compareing
The bacillus subtilis strain of separation or the composition as described in any one of claim 5 to 9) it compares, the treatment causes
The survival rate of shrimp at least increases by 10%, for example, at least 20%, for example, at least 30%, for example, at least 40%, for example, at least 50%, example
Such as at least 60% or for example, at least 70% higher survival rate.
12. the bacillus subtilis strain detached according to any one of claims 1 to 4 is appointed in such as claim 5 to 9
Composition described in one is used to be used as drug.
13. the bacillus subtilis strain detached according to any one of claims 1 to 4 is appointed in such as claim 5 to 9
Composition described in one is for treating prawn disease such as EMS.
14. the purposes of one or more bacillus subtilis strains, one or more bacillus subtilis strains are selected from down
Group, the group are made up of:
(a) bacillus subtilis strain O14VRQ with preservation accession number NRRL B-67221 or with bacillus subtilis bacterium
The bacterial strain or its mutant of all diagnostic characteristics of strain NRRL B-67221;And
(b) bacillus subtilis strain MF1048 with preservation accession number NRRL B-67220 or with bacillus subtilis bacterium
The bacterial strain or its mutant of all diagnostic characteristics of strain NRRL B-67220;
For treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS.
15. the purposes of the bacillus subtilis strain of one or more separation with 16S rDNA sequences, the 16S rDNA
Sequence is selected from the group, which is made up of:
(a) with SEQ ID NO:1 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least 98.15%,
At least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least 98.45%, at least
98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least 98.75%, at least
98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least 99.05%, at least
99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least 99.35%, at least
99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least 99.65%, at least
99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least 99.95% or 100% sequence
The 16s rDNA of row consistency;And
(b) with SEQ ID NO:2 have at least 98.00%, for example, at least 98.05%, at least 98.10%, at least 98.15%,
At least 98.20%, at least 98.25%, at least 98.30%, at least 98.35%, at least 98.40%, at least 98.45%, at least
98.50%, at least 98.55%, at least 98.60%, at least 98.65%, at least 98.70%, at least 98.75%, at least
98.80%, at least 98.85%, at least 98.90%, at least 98.95%, at least 99.00%, at least 99.05%, at least
99.10%, at least 99.15%, at least 99.20%, at least 99.25%, at least 99.30%, at least 99.35%, at least
99.40%, at least 99.45%, at least 99.50%, at least 99.55%, at least 99.60%, at least 99.65%, at least
99.70%, at least 99.75%, at least 99.80%, at least 99.85%, at least 99.90%, at least 99.95% or 100% sequence
The 16s rDNA of row consistency,
For treating shrimp Poisoning vibrio parahemolyticus relevant disease such as EMS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662298578P | 2016-02-23 | 2016-02-23 | |
US62/298,578 | 2016-02-23 | ||
PCT/US2017/018843 WO2017147130A2 (en) | 2016-02-23 | 2017-02-22 | Direct fed microbial for prevention of shrimp disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108603166A true CN108603166A (en) | 2018-09-28 |
Family
ID=58231730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780009209.6A Pending CN108603166A (en) | 2016-02-23 | 2017-02-22 | Direct-Fed Microbials for prevention of shrimp disease |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN108603166A (en) |
EC (1) | ECSP18071568A (en) |
WO (1) | WO2017147130A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111690558A (en) * | 2020-05-31 | 2020-09-22 | 青岛玛斯特生物技术有限公司 | Bacillus subtilis strain and application thereof in aquaculture |
CN115397264A (en) * | 2019-08-20 | 2022-11-25 | 孢子原有限公司 | Formula for preventing or reducing clostridium difficile infection |
CN116948890A (en) * | 2023-07-13 | 2023-10-27 | 江苏三仪生物工程有限公司 | Composite microecological microbial agent for inhibiting vibrio aquiculture and preparation method thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019040266A1 (en) * | 2017-08-23 | 2019-02-28 | Novozymes A/S | Direct fed microbials for improving the general condition and health of fish |
WO2019132605A1 (en) * | 2017-12-29 | 2019-07-04 | 씨제이제일제당 (주) | Feed composition containing bacilius subtilus strain as active ingredient for preventing or treating acute hepatopancreatic necrosis disease or white spot syndrome |
KR102277987B1 (en) * | 2017-12-29 | 2021-07-16 | 씨제이제일제당 주식회사 | A feed composition for the preventing or treating Acute Hepatopancreatic Necrosis Disease or White Spot Syndrome including Bacillus subtilus, Bacillus pumilus, and Bacillus licheniformis |
CN112251370B (en) * | 2020-09-03 | 2023-08-04 | 福建大北农华有水产科技集团有限公司 | Composite microecological preparation containing bacillus subtilis and application thereof |
CN112602859A (en) * | 2020-12-28 | 2021-04-06 | 东台市苏泰饲料有限公司 | Feed for preventing and controlling hepatopancreas necrosis syndrome of prawns |
CN116286447A (en) * | 2022-10-09 | 2023-06-23 | 集美大学 | Bacillus subtilis and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104411182A (en) * | 2012-04-12 | 2015-03-11 | 杜邦营养生物科学有限公司 | Microbial strains and their use in animals |
-
2017
- 2017-02-22 WO PCT/US2017/018843 patent/WO2017147130A2/en active Application Filing
- 2017-02-22 CN CN201780009209.6A patent/CN108603166A/en active Pending
-
2018
- 2018-09-21 EC ECSENADI201871568A patent/ECSP18071568A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104411182A (en) * | 2012-04-12 | 2015-03-11 | 杜邦营养生物科学有限公司 | Microbial strains and their use in animals |
Non-Patent Citations (4)
Title |
---|
DANIEL R ZEIGLER等: "The origins of 168, W23, and other Bacillus subtilis legacy strains", 《J BACTERIOL.》 * |
李桂英等: "几株肠道益生菌对凡纳滨对虾非特异免疫力和抗病力的影响", 《中国水产科学》 * |
李桂英等: "饲料中添加潜在益生菌对凡纳滨对虾肠道消化酶活性和菌群组成的影响", 《渔业科学进展》 * |
许玉洁等: "芽孢杆菌和溶藻弧菌对凡纳滨对虾消化酶、免疫酶活力及抗病力的影响", 《中国海洋大学学报(自然科学版)》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115397264A (en) * | 2019-08-20 | 2022-11-25 | 孢子原有限公司 | Formula for preventing or reducing clostridium difficile infection |
CN111690558A (en) * | 2020-05-31 | 2020-09-22 | 青岛玛斯特生物技术有限公司 | Bacillus subtilis strain and application thereof in aquaculture |
CN111690558B (en) * | 2020-05-31 | 2022-04-08 | 青岛玛斯特生物技术有限公司 | Bacillus subtilis strain and application thereof in aquaculture |
CN116948890A (en) * | 2023-07-13 | 2023-10-27 | 江苏三仪生物工程有限公司 | Composite microecological microbial agent for inhibiting vibrio aquiculture and preparation method thereof |
CN116948890B (en) * | 2023-07-13 | 2024-03-22 | 江苏三仪生物工程有限公司 | Composite microecological microbial agent for inhibiting vibrio aquiculture and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2017147130A2 (en) | 2017-08-31 |
ECSP18071568A (en) | 2018-10-31 |
WO2017147130A3 (en) | 2017-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240108666A1 (en) | Compositions and methods for improving the health of aquatic animals | |
CN108603166A (en) | Direct-Fed Microbials for prevention of shrimp disease | |
Ghosh et al. | Dietary probiotic supplementation in growth and health of live‐bearing ornamental fishes | |
CN1281147C (en) | Microbial fodder additive and its preparing method and use | |
US20160128337A1 (en) | Antibacterial compositions and methods of use | |
CN109673816A (en) | A kind of high-activity biological fermented feed used for aquiculture and preparation method thereof | |
JP5872104B2 (en) | New Bacillus subtilis {NOVELBACILLUSSUBTILIS} | |
CN103429093A (en) | Feed additive composition | |
CN103442587A (en) | Feed additive composition | |
Gómez et al. | Influence of probiotics on the growth and digestive enzyme activity of white Pacific shrimp (Litopenaeus vannamei) | |
CN103533843A (en) | Feed additive composition | |
Khanjani et al. | Aquamimicry system: a sutiable strategy for shrimp aquaculture–a review | |
Gule et al. | Dietary strategies for better utilization of aquafeeds in Tilapia farming | |
CN112868932A (en) | Pure meat cat food capable of improving digestion characteristic and relieving feces odor and preparation method thereof | |
Anuar et al. | Effect of commercial probiotics on the survival and growth performance of goldfish Carassius auratus | |
CN106720956A (en) | A kind of carp feed | |
CN109722392B (en) | Culture medium capable of promoting bacillus subtilis to produce spores and application thereof | |
JP2008048683A (en) | Viable bacteria agent for animal, feed composition, and method for using the agent and the composition | |
Totewad et al. | Effect of Probiotic Enterococcus gallinarum N3 Supplemented Feed on Growth Performance of Freshwater Fish Cyprinus carpio. | |
KR102026777B1 (en) | Method for preparing fermented soybean meal for replacing fishmeal using Anti-Nutritional Factor controlling strain Microbacterium hydrothemale KBCBS1021 | |
Sinha et al. | Probiotic effect of a live bacterial isolate in nutrition of an Indian major carp, rohu (Labeo rohita) | |
Gupta et al. | Effect of dietary probiotic improval (Lactobacillus sporogenes and Saccharomyces cerevisiae) on growth and feed utilization of Macrobrachium rosenbergii post larvae | |
KR102160918B1 (en) | Probiotics for feed including microbe | |
Ghosh et al. | Feed utilization efficiency and growth performance in rohu, Labeo rohita (Hamilton, 1822), fingerlings fed yeast extract powder supplemented diets | |
CN107183352A (en) | A kind of preparation technology of antibacterial peptide biological feedstuff |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180928 |